myoscience
iovera Wins Spark Design Award
myoscience 20.11.2013 13:00 --------------------------------------------------------------------------- REDWOOD CITY, Calif., 2013-11-20 13:00 CET (GLOBE NEWSWIRE) -- Myoscience is pleased to announce that the design for the iovera° system has won top honors in the Spark International design competition. The iovera° system was awarded the highest honor (Spark!) in the category of product design, which is a general category that includes medical devices as well as consumer electronics, cookware, and even sports equipment. Myoscience collaborated with LUNAR to design the iovera° system. 'We're honored to have worked with myoscience to design a beautiful and effective device that will help improve the quality of life for countless people,' says Jeff Salazar at LUNAR. The Spark Awards are given based on two primary criteria: the design innovation and creativity, and the impact it will have on quality of life. The iovera° system is a new take on the safe and reliable use of cold in medicine; by miniaturizing and refining the delivery system to be smaller and more precise, the treatments can be tailored to specific indications. The iovera° system has already improved the quality of life for many who have been treated, immediately reducing pain and enabling people to return to their favorite activities as well as smoothing forehead wrinkles for improved appearance. The iovera˚ system, developed by myoscience, inc. in California, harnesses the power of cold using Focused Cold Therapy(TM), the advanced technology that powers the device. The iovera° treatment works immediately for both health and beauty applications without leaving any toxins or chemicals behind in the body. iovera° is approved in the European Union and Canada for the treatment of wrinkles, and is used for the treatment of pain in the United States. 'We designed the iovera° system to be sophisticated and intuitive,' says myoscience CEO Clint Carnell. 'It has only one button and fits ergonomically in the physician's hand. Our talented team of engineers and the team of designers at LUNAR who worked hard to ensure we created a product that is not only beautiful to look at, but delivers an elegant result that will immediately ease pain or reduce wrinkles. I am very proud of my team at myoscience who made this concept into a reality.' To see the full list of awards: http://www.sparkawards.com/about/news/ To see the press release from Spark: http://www.prweb.com/releases/2013/11/prweb11336709.htm ABOUT THE SPARK AWARD The Spark mission is to promote better living through better design. The criteria are the same for all Spark competitions: does the design 'Spark,' i.e., innovate, change the game and in some way help humanity or the environment we live in. The Spark founders believe Design is an important, relevant tool to help build a better world. We feel that Design and designers act as catalysts, addressing problems and improving our lives and our Earth. www.sparkawards.com ABOUT MYOSCIENCE Silicon Valley, California-based myoscience is a privately-held medical device company committed to making its platform technology, Focused Cold TherapyTM, the standard of care for the treatment of peripheral nerve conditions. Focused Cold Therapy is the technology underlying the iovera° treatment, which is currently approved in Europe and Canada for temporary wrinkle reduction, temporary pain reduction and treatment of dermatologic conditions. iovera° has also been cleared in the United States for use in pain management and general surgical use. For more information, please visit www.myoscience.com. The myoscience logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13581 (c) 2013 myoscience. All rights reserved. iovera° and Focused Cold Therapy are trademarks of myoscience. MKT-0106A CONTACT: MEDIA RELATIONS Alexandra Mack / mediarelations@myoscience.com 650-474-2600 News Source: NASDAQ OMX 20.11.2013 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: myoscience United States Phone: Fax: E-mail: Internet: ISIN: US9902131674 WKN: End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden